Novo CEO pressed by Senate to chop selling prices of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would contemplate new talks with insurers in regards to the checklist rates of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Before this summer, https://labelthefigurewiththeitem27261.get-blogging.com/31150383/considerations-to-know-about-healthcare-news